Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Withdrawn 2Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Esophageal Neoplasms 2Sarcoma 1Colorectal Neoplasms 1Childhood Brain Neoplasm 1Brain Neoplasms 1

Interventions

Paclitaxel 5Radiotherapy 3Fluorouracil 3Carboplatin 3nimotuzumab 2Taxes 2S 1 (combination) 2Radiation 2Oxaliplatin 2Nivolumab 2Ferrosoferric Oxide 2Drug Therapy 2Cisplatin 2Cetuximab 2pembrolizumab 1entinostat 1atezolizumab 1apatinib 1Watchful Waiting 1Trastuzumab 1TH 302 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Radiotherapy, Intensity-Modulated 1Proton Therapy 1Polymerase Chain Reaction 1Observation 1Nimodipine 1Magnetic Resonance Spectroscopy 1Lubricant Eye Drops 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Esophageal Neoplasms × Ferrosoferric Oxide × Clear all
NCT02857218 2021-09-16

Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Stage IIB-IIIC Esophageal Cancer

OHSU Knight Cancer Institute

Phase EARLY_PHASE1 Withdrawn
Gastrointestinal

Esophageal Neoplasms

NCT02689401 2016-05-13

MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancer

Dana-Farber Cancer Institute

Phase 1 Withdrawn
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡